Cargando…

Cerebral mTOR signal and pro-inflammatory cytokines in Alzheimer’s disease rats

As a part of Alzheimer’s disease (AD) development the mammalian target of rapamycin (mTOR) has been reported to play a crucial role in regulating cognition and can be used as a neuronal marker. Neuro-inflammation is also a cause of the pathophysiological process in AD. Thus, we examined the protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xu, Li, Guang-Jian, Hu, Hai-Xia, Ma, Chi, Ma, Di-Hui, Liu, Xiao-Liang, Jiang, Xiao-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter Open 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234524/ https://www.ncbi.nlm.nih.gov/pubmed/28123835 http://dx.doi.org/10.1515/tnsci-2016-0022

Ejemplares similares

Activation of mTOR: a culprit of Alzheimer’s disease?
por: Cai, Zhiyou, et al.
Publicado: (2015)

Functional animal proteins activate mTOR and bind pro-inflammatory compounds
por: Detzel, Christopher J, et al.
Publicado: (2015)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

mTOR-dependent signalling in Alzheimer's disease
por: Pei, Jin-Jing, et al.
Publicado: (2008)

Inhibition of mTOR signaling Confers Protection against Cerebral Ischemic Injury in Acute Hyperglycemic Rats
por: Hei, Changchun, et al.
Publicado: (2017)

mTOR sustains inflammatory response in celiac disease
por: Sedda, S., et al.
Publicado: (2020)

The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells
por: Cappoli, Natalia, et al.
Publicado: (2019)

Combinatorial Regimen of Carbamazepine and Imipramine Exhibits Synergism against Grandmal Epilepsy in Rats: Inhibition of Pro-Inflammatory Cytokines and PI3K/Akt/mTOR Signaling Pathway
por: Pottoo, Faheem Hyder, et al.
Publicado: (2021)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

mTOR: Alzheimer's disease prevention for APOE4 carriers
por: Lin, Ai-Ling, et al.
Publicado: (2016)

Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development
por: Mueed, Zeba, et al.
Publicado: (2019)

Overview of Research into mTOR Inhibitors
por: Mao, Beibei, et al.
Publicado: (2022)

Vibrio vulnificus induces mTOR activation and inflammatory responses in macrophages
por: Xie, Dan-Li, et al.
Publicado: (2017)

mTOR signaling-related MicroRNAs and Cancer involvement
por: WANG, Ping, et al.
Publicado: (2018)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway
por: Addie, Ruben D., et al.
Publicado: (2019)

Resveratrol Activates Autophagy via the AKT/mTOR Signaling Pathway to Improve Cognitive Dysfunction in Rats With Chronic Cerebral Hypoperfusion
por: Wang, Nan, et al.
Publicado: (2019)

Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s disease
por: Yates, Sharon C, et al.
Publicado: (2013)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
por: Ma, Jing, et al.
Publicado: (2023)

The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus
por: Wang, Nan, et al.
Publicado: (2015)

Effects of propofol on LC3II and mTOR/p-mTOR expression during ischemia-reperfusion myocardium injury in rats with type 2 diabetes mellitus
por: Wang, Ying, et al.
Publicado: (2020)

Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic carcinoma cells
por: Dai, Zhi-Jun, et al.
Publicado: (2013)

mTOR and lysosome regulation
por: Puertollano, Rosa
Publicado: (2014)

mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)

mTOR and Tumor Cachexia
por: Duval, Adrian P., et al.
Publicado: (2018)

Double agent mTOR
por: Danzer, Steve C.
Publicado: (2019)

mTOR in Human Diseases
por: Dormond, Olivier
Publicado: (2019)

Dendrite pathology and neurodegeneration: focus on mTOR
por: Di Polo, Adriana
Publicado: (2015)

Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer’s Disease
por: Lee, Jennifer, et al.
Publicado: (2018)

Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
por: Renna, Maurizio
Publicado: (2016)

Impact of mTOR gene polymorphisms and gene-tea interaction on susceptibility to tuberculosis
por: Wang, Mian, et al.
Publicado: (2020)

The role of mTOR signaling pathway on cognitive functions in cerebral ischemia-reperfusion
por: Yang, Liying, et al.
Publicado: (2017)

Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression
por: Wu, Mingsong, et al.
Publicado: (2015)

Regulation of mTOR, Metabolic Fitness, and Effector Functions by Cytokines in Natural Killer Cells
por: Viel, Sébastien, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ibcome6e0mdq8frcnj82p01fgt